Wolverine Trading
PACB icon

Wolverine Trading’s Pacific Biosciences PACB Stock Holding History

Wolverine Trading’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$81.6K Buy
65,300
+12,600
+24% +$17.1K ﹤0.01% 5274
2025
Q2 		$68K Sell
52,700
-14,100
-21% -$16.3K ﹤0.01% 4269
2025
Q1 		$76.2K Sell
66,800
-12,000
-15% -$18.4K ﹤0.01% 4298
2024
Q4 		$141K Buy
78,800
+6,800
+9% +$13.3K ﹤0.01% 4683
2024
Q3 		$126K Buy
72,000
+17,100
+31% +$28.1K ﹤0.01% 4281
2024
Q2 		$75.2K Buy
54,900
+25,000
+84% +$50.5K ﹤0.01% 4147
2024
Q1 		$112K Sell
29,900
-76,100
-72% -$446K ﹤0.01% 4020
2023
Q4 		$1.04M Buy
106,000
+8,200
+8% +$67.1K ﹤0.01% 2268
2023
Q3 		$817K Sell
97,800
-56,200
-36% -$642K ﹤0.01% 2294
2023
Q2 		$2.02M Buy
154,000
+117,100
+317% +$1.42M ﹤0.01% 1472
2023
Q1 		$360K Buy
+36,900
New +$367K ﹤0.01% 2833
2019
Q1 		– Sell
-10,000
Closed -$73K – 5094
2018
Q4 		$73K Sell
10,000
-1,500
-13% -$9.5K ﹤0.01% 4078
2018
Q3 		$62K Buy
+11,500
New +$49.3K ﹤0.01% 4664
2017
Q4 		– Sell
-21,400
Closed -$112K – 5327
2017
Q3 		$112K Buy
+21,400
New +$92K ﹤0.01% 4037
2016
Q3 		– Sell
-23,500
Closed -$173K – 4977
2016
Q2 		$173K Buy
+23,500
New +$215K ﹤0.01% 3375

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Wolverine Trading's PACB Position: Q3 2025 in Review

Wolverine Trading reduced its Pacific Biosciences (PACB) stake by 3.2% in Q3 2025, selling an estimated $2.64K and leaving 59,213 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

Wolverine Trading first reported a position in PACB in Q2 2016 and has held it in 12 quarters since. The position peaked at $250K in Q2 2016. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • Wolverine Trading held 59,213 shares of Pacific Biosciences worth $74K as of Q3 2025.
  • Wolverine Trading sold 1,952 Pacific Biosciences shares in Q3 2025, an estimated $2.64K.
  • Pacific Biosciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5316 holding.
  • Wolverine Trading first reported a position in Pacific Biosciences in Q2 2016 and has held it in 12 quarters since.
  • Wolverine Trading's Pacific Biosciences position peaked at $250K in Q2 2016.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.